#  From fruit fly study to clinical trials: potential lung cancer treatment advances to clinical trials 

 





October 08, 2018

 

 

Paul Taylor ([University of Leeds](https://physicalsciences.leeds.ac.uk/staff/210/professor-paul-taylor)) announced [on Twitter](https://twitter.com/PaulfrYorkshire/status/1048324721752850432) on Oct. 5, 2018 that a drug identified "thanks to fruit flies" is now in clinical trials as a potential treatment for lung cancer. A *Drosophila* chemical genomics research study in which the compound was identified was published in 2017 in *Cancer Letters* and can be viewed [here](https://www.sciencedirect.com/science/article/pii/S0304383517300848). Coverage from a business perspective is available at proactiveinvestors.co.uk and include [this post](https://www.proactiveinvestors.co.uk/companies/news/193444/valirx-receives-us-patent-protection-for-exciting-lead-cancer-drug-193444.html) on US patent approval.

 

 

 



 

 See also:- [ all ](/usertype/all)
- [ biologists (non-fly experts) ](/usertype/biologists-non-fly-experts)
- [ Drosophila experts ](/usertype/drosophila-experts)
- [ physician-scientists ](/usertype/physician-scientists)
- [ the public ](/usertype/public)
 
 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)